Shares of Vital Therapies fell 5% Friday morning, after the company sold stock to support continued development of its system for patients suffering acute liver failure.
from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1vknaPx
Cap comentari:
Publica un comentari a l'entrada